Reported May 1, 2013 · Terminated

GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals,…

Qualitest Pharmaceuticals

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Qualitest Pharmaceuticals · 120 Vintage Dr NE · Huntsville, AL · 35811-8216

Is this the product you have?

  • GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only
  • Manufactured forQualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21
Lot codes and dates
    • Lot #: C0671212A
    • Exp 12/14
Amount recalled
10,373 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Qualitest Pharmaceuticals recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jan 13, 2014 · Data as of Sep 19, 7:57 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.